Therac-25: Physicians in Charge (Relevant Facts (-Marketed by Atomic…
Therac-25: Physicians in Charge
Alternative 1: Report malfunction of Therac-25 and run the risk of machine shut down
No more incidents of burns
Therac-25 software will be looked at and possibly fixed
Lives could have been saved
Wouldn't be any more cases of excess radiation given
Machine could be shut down
Cancer patients aren't able to use machine
AECL and FDA could shut the whole project down
AECL because they are marketing a product that is not efficient, but if fixed they are marketing a successful product
Patients will not have the risk factor of being burned
Who could be hurt?
Cancer patients because they are not able to use the machine for their treatments
Employees/Physicians because business would decline.
Whose right may be abridged?
-Marketed by Atomic Energy of Canada Unlimited (AECL)
-"25" refers to power of machine
-Substantially greater than Therac-6 and Therac-20
-6 accidents associated with machine
-First radiation overdose in 1985
-Three deaths resulted from Therac-25 software malfunction
-Had no hardware safguards
-Software responsible for all safety issues
-Programmed by one programmer in an assembly language
Alternative 2: Do not report malfunction in hopes it was a fluke
Machine able to continue to help cancer patients
No one runs the risk of getting in trouble
Could damage the company providing the machines reuptation
Physicians could lose their job and/or license
Lawsuits could ruin the entire company
More people will get injured and possibly die
Whose rights may be abridged?
The programmer could have his rights took for creating software's because of his negligence.
Who could be hurt?
Patients could be burned and it could possibly be fatal.
Programmer because he was negligent when creating the software
Physicians because they are not reporting the complaints
AECL because they are marketing the product that they are unaware is defective.
List of stakeholders
Physician in Charge
Quality Assurance Officer
What can be done in the future?